GO:0006212 uracil catabolic process: Uracil Breakdown Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006212 (uracil catabolic process) describes the chemical reactions and pathways that break down uracil, a pyrimidine base found in RNA but not DNA.
• Uracil catabolism is distinct from uracil repair; repair enzymes such as SMUG1 and endonuclease III remove uracil from DNA, whereas catabolic enzymes degrade the free base.
• Key catabolic steps include reduction of uracil to dihydrouracil and further hydrolysis to beta-alanine, although the exact human enzyme repertoire remains incompletely defined in the provided literature.
• Uracil and its analogs can act as antiviral and antimicrobial weapons, and viruses have evolved escape mechanisms against uracil-based drugs.
• Dysregulated uracil metabolism is linked to cancer, mitochondrial dysfunction, and altered gut immunity, making it a target for functional genomics.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect the causal roles of uracil catabolic genes in disease.
Description
Uracil is one of the four RNA bases and a central intermediate in pyrimidine metabolism. The Gene Ontology term GO:0006212, uracil catabolic process, defines the set of biochemical reactions that result in the breakdown of uracil, 2,4-dioxopyrimidine. This process is fundamental for nucleotide homeostasis, nitrogen recycling, and the detoxification of excess pyrimidines. Unlike uracil repair, which removes uracil misincorporated into DNA, catabolism degrades the free base and its derivatives. Understanding uracil catabolism is critical because uracil analogs are used as antiviral and anticancer agents, and because uracil-induced signaling can modulate immunity. Moreover, defects in uracil catabolism have been associated with severe clinical phenotypes, including mitochondrial dysfunction and neurological abnormalities. The pathway also intersects with salvage and de novo synthesis routes, making it a hub for metabolic regulation. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0006212, its genes, mechanisms, disease links, and experimental models.
uracil catabolic process At A Glance
| GO ID | GO:0006212 |
|---|---|
| GO term | uracil catabolic process |
| Ontology | biological_process |
| Synonym | uracil breakdown; uracil catabolism; uracil degradation |
| Major function | Breakdown of uracil to dihydrouracil and beta-alanine |
| Related process | Pyrimidine catabolism, beta-alanine metabolism |
| Key enzymes | Dihydropyrimidine dehydrogenase (DPYD), dihydropyrimidinase (DPYS), beta-ureidopropionase (UPB1) |
| Cellular location | Cytosol, mitochondria |
| Disease relevance | Cancer, mitochondrial dysfunction, neurological disorders |
What Is GO:0006212?
The uracil catabolic process (GO:0006212) is the series of chemical reactions and pathways that result in the breakdown of uracil, a pyrimidine base that occurs in RNA but not in DNA. This process typically involves the reduction of uracil to dihydrouracil, followed by hydrolysis to beta-alanine and other metabolites, although the exact enzymatic steps may vary across organisms. It is a biological process distinct from uracil repair and salvage.
Why Is uracil catabolic process Important in Cell Biology?
Uracil catabolism is essential for maintaining pyrimidine homeostasis and preventing the toxic accumulation of uracil and its analogs. It influences the efficacy and toxicity of chemotherapeutic and antiviral drugs, and it modulates immune signaling in the gut. Defects in catabolic enzymes can lead to severe metabolic disorders, and the pathway is increasingly recognized as a target in cancer and infectious disease research.
• Maintains balanced pyrimidine pools and prevents uracil toxicity.
• Determines the pharmacokinetics and toxicity of uracil-based drugs such as 5-fluorouracil.
• Links to mitochondrial energy metabolism and neurodegeneration.
• Modulates DUOX-dependent gut immunity in response to uracil.
• Provides a source of beta-alanine for carnosine synthesis and other pathways.
• Serves as a model for studying enzyme evolution and substrate specificity.
• Relevant to antiviral defense, as viruses escape uracil-based restriction.
• Potential biomarker for dihydropyrimidine dehydrogenase deficiency.
• Target for CRISPR screens to identify novel catabolic regulators.
• Informs synthetic biology approaches to engineer pyrimidine degradation.
What Happens During uracil catabolic process?
Uracil uptake and activation
In simple terms: Uracil enters the cell and is prepared for breakdown.
Uracil can be taken up from the environment or generated from nucleotide turnover. In some organisms, uracil transporters facilitate its entry. Once inside, uracil may be activated or directly channeled into catabolic enzymes. The regulation of uracil uptake is critical for its availability as a substrate.
Reduction to dihydrouracil
In simple terms: Uracil loses two hydrogen atoms to become dihydrouracil.
The first committed step in uracil catabolism is the reduction of uracil to 5,6-dihydrouracil, catalyzed by dihydropyrimidine dehydrogenase (DPYD). This enzyme uses NADPH as a cofactor and is rate-limiting for the pathway. Deficiencies in DPYD lead to uracil accumulation and severe toxicity upon 5-fluorouracil treatment.
Hydrolysis to beta-alanine
In simple terms: Dihydrouracil is split into beta-alanine and ammonia.
Dihydrouracil is further hydrolyzed by dihydropyrimidinase (DPYS) to beta-ureidopropionate, which is then converted by beta-ureidopropionase (UPB1) to beta-alanine, ammonia, and carbon dioxide. Beta-alanine is a precursor for carnosine and other dipeptides. This step is essential for nitrogen recycling.
Regulation and integration with other pathways
In simple terms: The breakdown of uracil is controlled and linked to other metabolic routes.
Uracil catabolism is regulated at the transcriptional and post-translational levels, and it intersects with pyrimidine salvage and de novo synthesis. For example, uracil-induced signaling can activate DUOX-dependent immune responses in the gut. Additionally, uracil analogs can interfere with viral replication, and viruses have evolved mechanisms to counteract uracil incorporation.
Key Genes Involved in GO:0006212 uracil catabolic process
The following genes and proteins are directly or indirectly involved in uracil catabolic process (GO:0006212) and related pyrimidine metabolism.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DPYD | Dihydropyrimidine dehydrogenase; reduces uracil to dihydrouracil | Rate-limiting enzyme; target for 5-FU toxicity studies |
| DPYS | Dihydropyrimidinase; hydrolyzes dihydrouracil | Deficiency causes dihydropyrimidinuria |
| UPB1 | Beta-ureidopropionase; produces beta-alanine | Linked to beta-alanine metabolism and neurological disorders |
| SMUG1 | Uracil-DNA glycosylase; removes uracil from DNA | Distinct from catabolism but relevant to uracil repair |
| UNG | Uracil-DNA glycosylase; base excision repair | Prevents mutagenesis; not catabolic |
| NTHL1 | Endonuclease III; repairs oxidized pyrimidines | Involved in uracil repair |
| DUOX2 | NADPH oxidase; produces ROS in response to uracil | Uracil-induced gut immunity |
| SLC23A2 | Nucleobase transporter; may transport uracil | Uracil uptake in non-mammalian cells |
| TK1 | Thymidine kinase; salvage of pyrimidines | Indirectly affects uracil pools |
| TYMS | Thymidylate synthase; de novo pyrimidine synthesis | Balances uracil levels |
| CMPK1 | UMP-CMP kinase; pyrimidine salvage | Regulates nucleotide pools |
| NT5C | Nucleotidase; dephosphorylates pyrimidines | Contributes to uracil generation |
| UPP1 | Uridine phosphorylase; produces uracil | Links salvage to catabolism |
| UPP2 | Uridine phosphorylase 2; produces uracil | Tissue-specific uracil generation |
| PYCR1 | Pyrroline-5-carboxylate reductase; not directly catabolic | May influence pyrimidine metabolism |
| GLS | Glutaminase; provides nitrogen for pyrimidines | Indirect role in uracil synthesis |
How Is uracil catabolic process Regulated?
Uracil catabolic process is regulated at multiple levels. DPYD expression is controlled by transcription factors and microRNAs, and its activity is sensitive to NADPH availability. Uracil itself can induce signaling pathways, such as DUOX-dependent ROS production in the gut. Additionally, viral proteins can inhibit uracil catabolism or incorporation to escape antiviral effects. Post-translational modifications of catabolic enzymes, including phosphorylation and ubiquitination, further modulate pathway flux.
uracil catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DPYD | Dihydropyrimidine dehydrogenase deficiency; 5-FU toxicity | Knockout cell line; point mutation knock-in |
| DPYS | Dihydropyrimidinuria; neurological symptoms | Knockout mouse; overexpression |
| UPB1 | Beta-ureidopropionase deficiency; beta-alanine accumulation | Knock-in of patient variants |
| SMUG1 | Uracil repair deficiency; cancer predisposition | Knockout; tagged knock-in |
| DUOX2 | Gut immunity; inflammatory bowel disease | Overexpression; knockout |
Dihydropyrimidine dehydrogenase deficiency and 5-FU toxicity
Mutations in DPYD cause dihydropyrimidine dehydrogenase deficiency, leading to uracil accumulation and severe toxicity upon administration of 5-fluorouracil, a common chemotherapeutic agent. Patients may experience myelosuppression, mucositis, and neurotoxicity. Screening for DPYD variants is recommended before 5-FU treatment.
Uracil catabolism and mitochondrial dysfunction
Impaired uracil catabolism has been linked to mitochondrial dysfunction and neurological abnormalities, as seen in dihydropyrimidinase deficiency. The accumulation of uracil and dihydrouracil may interfere with mitochondrial energy production and cause oxidative stress.
Uracil as an antiviral and immune modulator
Uracil and its analogs can act as antiviral agents by incorporating into viral RNA and causing lethal mutagenesis. Conversely, uracil-induced signaling can activate DUOX-dependent gut immunity, highlighting a role in host defense. Viruses have evolved escape mechanisms, such as uracil-DNA glycosylase, to counteract these effects.
From uracil catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does DPYD loss alter uracil catabolism? | CRISPR knockout in HepG2 or HEK293T |
| Does a specific DPYD variant affect enzyme activity? | Point mutation knock-in |
| Can overexpression of DPYS rescue uracil accumulation? | Overexpression cell line |
| Where is DPYD localized in the cell? | Tagged knock-in (e.g., GFP) |
| What genes regulate uracil catabolism? | CRISPR library screening |
| Does uracil catabolism affect drug sensitivity? | Knockout + drug treatment |
How to Study the uracil catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Uracil, dihydrouracil, beta-alanine levels | Quantify pathway flux |
| Enzyme activity assay | DPYD, DPYS, UPB1 catalytic rates | Validate variants |
| CRISPR knockout screen | Gene essentiality and drug sensitivity | Identify regulators |
| RNA-seq | Transcriptional changes | Pathway crosstalk |
| Proteomics | Protein abundance and modifications | Post-translational regulation |
| Immunofluorescence | Subcellular localization | Enzyme trafficking |
| Stable isotope tracing | Metabolic flux | In vivo pathway dynamics |
Metabolomics and flux analysis
Liquid chromatography-mass spectrometry (LC-MS) can quantify uracil, dihydrouracil, and beta-alanine levels to assess catabolic flux. Stable isotope tracing with 13C-uracil can reveal pathway dynamics.
Enzymatic assays
Recombinant DPYD, DPYS, and UPB1 can be used in in vitro assays to measure catalytic activity and kinetics. These assays help validate the effects of mutations identified in patients.
CRISPR screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate uracil catabolism or sensitivity to uracil analogs. Hits can be validated with targeted knockouts.
RNA-seq and proteomics
Transcriptomic and proteomic profiling of cells with altered uracil catabolism can reveal downstream pathways and compensatory mechanisms.
How CRISPR Can Be Used to Study GO:0006212 uracil catabolic process
Knockout
CRISPR knockout of DPYD, DPYS, or UPB1 can create cell models to study uracil catabolism deficiency. These models are useful for drug sensitivity testing and metabolic profiling.
Point Mutation
Introducing patient-specific point mutations (e.g., DPYD*2A) via CRISPR base editing or HDR allows functional assessment of enzyme variants and their impact on uracil catabolism.
Knock-in
Knock-in of tagged versions (e.g., GFP, FLAG) of catabolic enzymes enables live-cell imaging and proteomic studies. Knock-in of reporter genes under endogenous promoters can monitor pathway activity.
Overexpression
Overexpression of DPYD, DPYS, or UPB1 can rescue uracil accumulation or enhance catabolic flux. These models are valuable for testing whether increased catabolism alters drug responses.
How EDITGENE Supports uracil catabolic process Research
Researchers studying uracil catabolic process-related genes often need to determine whether a candidate gene is causally involved in uracil breakdown, drug toxicity, or disease. EDITGENE provides custom CRISPR cell models to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for uracil catabolic process research.
Frequently Asked Questions About uracil catabolic process
What is uracil catabolic process?
Uracil catabolic process (GO:0006212) is the breakdown of uracil into dihydrouracil and beta-alanine, a key pathway in pyrimidine metabolism.
What genes are involved in uracil catabolic process?
Key genes include DPYD, DPYS, and UPB1, which encode enzymes that sequentially degrade uracil.
How is uracil catabolism different from uracil repair?
Uracil catabolism degrades the free base, while uracil repair removes uracil from DNA via glycosylases like SMUG1 and UNG.
What diseases are linked to uracil catabolic process?
DPYD deficiency causes severe 5-FU toxicity; DPYS and UPB1 deficiencies lead to neurological and metabolic disorders.
What is the role of DPYD in uracil catabolism?
DPYD catalyzes the rate-limiting reduction of uracil to dihydrouracil and is critical for drug metabolism.
Can CRISPR be used to study uracil catabolism?
Yes, CRISPR knockout, point mutation, and knock-in models are powerful tools to dissect gene function in uracil catabolism.
What are the products of uracil catabolism?
The main products are dihydrouracil, beta-ureidopropionate, beta-alanine, ammonia, and carbon dioxide.
How is uracil catabolism regulated?
It is regulated by transcription, NADPH availability, and signaling pathways such as DUOX-dependent immunity.
What methods study uracil catabolism?
LC-MS metabolomics, enzyme assays, CRISPR screens, and RNA-seq are commonly used.
Why is uracil catabolism important in cancer?
It determines the toxicity and efficacy of 5-fluorouracil and other pyrimidine analogs used in chemotherapy.
Conclusion
GO:0006212 uracil catabolic process is a fundamental metabolic pathway with broad implications for drug metabolism, immunity, and disease. Understanding its genes and regulation can inform therapeutic strategies and biomarker development. EDITGENE provides comprehensive CRISPR solutions to study this pathway in relevant cell models.
References
- 1. Ludäscher JM et al.. 2026. Structural basis for uracil removal from DNA by human SMUG1.. Nat Commun 17(1) PMID: 42230560
- 2. Holzhüter K et al.. 2022. Uniport, Not Proton-Symport, in a Non-Mammalian SLC23 Transporter.. J Mol Biol 434(2):167393 PMID: 34896363
- 3. Yang Y et al.. 2019. Role of endonuclease III enzymes in uracil repair.. Mutat Res 813:20-30 PMID: 30590231
- 5. Lee KA et al.. 2015. Uracil-induced signaling pathways for DUOX-dependent gut immunity.. Fly (Austin) 9(3):115-20 PMID: 26655037
- 7. Bjelland S et al.. 2001. Cellular effects of 5-formyluracil in DNA.. Mutat Res 486(2):147-54 PMID: 11425519
- 8. Priet S et al.. 2006. Uracils as a cellular weapon against viruses and mechanisms of viral escape.. Curr HIV Res 4(1):31-42 PMID: 16454709
